Post‑operative urothelial recurrence in patients with upper urinary tract urothelial carcinoma managed by radical nephroureterectomy with an ipsilateral bladder cuff: Minimal prognostic impact in comparison with non‑urothelial recurrence and other clinical indicators

Takahara,Kiyoshi; Inamoto,Teruo; Komura,Kazumasa; Watsuji,Toshikazu; Azuma,Haruhito

doi:10.3892/ol.2013.1485

Post‑operative urothelial recurrence in patients with upper urinary tract urothelial carcinoma managed by radical nephroureterectomy with an ipsilateral bladder cuff: Minimal prognostic impact in comparison with non‑urothelial recurrence and other clinical indicators

Authors:
- Kiyoshi Takahara
- Teruo Inamoto
- Kazumasa Komura
- Toshikazu Watsuji
- Haruhito Azuma
View Affiliations

Affiliations: Department of Urology, Osaka Medical College, Osaka, Japan, Department of Urology, Hirakata City Hospital, Osaka, Japan
Published online on: July 23, 2013 https://doi.org/10.3892/ol.2013.1485
Pages: 1015-1020

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Upper urinary tract urothelial carcinoma (UTUC) is a rare disease, and novel prognostic factors for patients who have undergone a radical nephroureterectomy (RNU) for UTUC have been studied intensely. To the best of our knowledge, the prognostic value of urothelial recurrence in patients with UTUC has not been previously described in studies. The present study compared the prognostic value of urothelial and non‑urothelial recurrence in patients with UTUC of the kidney and ureter managed by surgery. The inclusion criteria consisted of a diagnosis of non‑metastatic UTUC (any T stage, N0‑1 and M0) and receipt of an RNU with an ipsilateral bladder cuff as the primary treatment. Of the 153 patients that were screened for the study, comprehensive clinical and pathological data was available for 103 patients, who were consequently included in the analysis. Overall survival (OS) and cancer‑specific survival (CSS) times were estimated. A multivariate analysis was performed using the Cox regression model. The median follow‑up period was 29 months (interquartile range, 14‑63 months). The patient population was comprised of 71 males (68.9%) and 32 females (31.1%). A total of 32 patients (31.1%) showed non‑urothelial recurrence, while 38 patients (36.9%) exhibited urothelial recurrence and 33 patients (32.0%) exhibited no recurrence. When comparing the risk parameters between the non-urothelial recurrence categories, the factors of pathological grade, microvascular invasion, lymphatic invasion and pT classification showed significant differences. However, there were no significant differences between the urothelial recurrence categories. No significant difference was observed between the OS and CSS times within the urothelial recurrence categories (P=0.3955 and P=0.05891, respectively), but significant differences were identified in the non‑urothelial recurrence categories (P<0.0001 and P<0.0001, respectively). Among the other relevant descriptive pre‑operative characteristics in the multivariate analysis, only non‑urothelial recurrence remained associated with a worse CSS [P=0.002; hazard ratio (HR) 9.512]. The results show that urothelial recurrence has a minimal prognostic value in patients with UTUC managed by RNU with an ipsilateral bladder cuff.

View Figures

View References

1	Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
2	Margulis V, Youssef RF, Karakiewicz PI, et al; Upper Tract Urothelial Carcinoma Group. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol. 184:453–458. 2010. View Article : Google Scholar : PubMed/NCBI
3	Oosterlinck W, Solsona E, van der Meijden AP, et al; European Association of Urology. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol. 46:147–154. 2004. View Article : Google Scholar : PubMed/NCBI
4	Raman JD and Scherr DS: Management of patients with upper urinary tract transitional cell carcinoma. Nat Clin Pract Urol. 4:432–443. 2007. View Article : Google Scholar : PubMed/NCBI
5	Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD and Roehrborn CG: Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 52:594–601. 1998.PubMed/NCBI
6	Langner C, Hutterer G, Chromecki T, Winkelmayer I, Rehak P and Zigeuner R: pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract. Mod Pathol. 19:272–279. 2006. View Article : Google Scholar : PubMed/NCBI
7	Novara G, De Marco V, Gottardo F, et al: Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer. 110:1715–1722. 2007. View Article : Google Scholar
8	Secin FP, Koppie TM, Salamanca JI, et al: Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer. Int J Urol. 14:26–32. 2007. View Article : Google Scholar : PubMed/NCBI
9	Brown GA, Busby JE, Wood CG, et al: Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm? BJU Int. 98:1176–1180. 2006. View Article : Google Scholar : PubMed/NCBI
10	Waldert M, Karakiewicz PI, Raman JD, et al: A delay in radical nephroureterectomy can lead to upstaging. BJU Int. 105:812–817. 2010. View Article : Google Scholar : PubMed/NCBI
11	Zigeuner R, Shariat SF, Margulis V, et al: Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol. 57:575–581. 2010. View Article : Google Scholar : PubMed/NCBI
12	Margulis V, Shariat SF, Matin SF, et al; The Upper Tract Urothelial Carcinoma Collaboration. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 115:1224–1233. 2009. View Article : Google Scholar : PubMed/NCBI
13	Epstein JI, Amin MB, Reuter VR and Mostofi FK: The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol. 22:1435–1448. 1998. View Article : Google Scholar
14	Eng MK and Shalhav AL: Laparoscopic nephroureterectomy: long-term outcomes. Curr Opin Urol. 18:157–162. 2008. View Article : Google Scholar : PubMed/NCBI
15	Kikuchi E, Margulis V, Karakiewicz PI, et al: Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol. 27:612–618. 2009. View Article : Google Scholar : PubMed/NCBI
16	Remzi M, Haitel A, Margulis V, et al: Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int. 103:307–311. 2009. View Article : Google Scholar : PubMed/NCBI
17	Otto W, Shariat SF, Fritsche HM, et al: Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. World J Urol. 29:487–494. 2011. View Article : Google Scholar : PubMed/NCBI
18	Koda S, Mita K, Shigeta M and Usui T: Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery. Jpn J Clin Oncol. 37:296–301. 2007. View Article : Google Scholar : PubMed/NCBI
19	Kusuda Y, Miyake H, Terakawa T, Kondo Y, Miura T and Fujisawa M: Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy. Urol Oncol. Aug 6–2011.(Epub ahead of print).
20	Terakawa T, Miyake H, Muramaki M, Takenaka A, Hara I and Fujisawa M: Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Urology. 71:123–127. 2008. View Article : Google Scholar : PubMed/NCBI
21	Pieras E, Frontera G, Ruiz X, Vicens A, Ozonas M and Pizá P: Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int. 106:1319–1323. 2010. View Article : Google Scholar
22	Wu WJ, Ke HL, Yang YH, Li CC, Chou YH and Huang CH: Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy? J Urol. 183:56–61. 2010. View Article : Google Scholar
23	Novara G, De Marco V, Dalpiaz O, et al: Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers. Int J Urol. 16:187–191. 2009. View Article : Google Scholar
24	Youssef RF, Shariat SF, Lotan Y, et al: Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma. Urology. 77:861–866. 2011. View Article : Google Scholar : PubMed/NCBI
25	Remzi M, Shariat S, Huebner W, Fajkovic H and Seitz C: Upper urinary tract urothelial carcinoma: what have we learned in the last 4 years? Ther Adv Urol. 3:69–80. 2011.PubMed/NCBI
26	Lehmann J, Suttmann H, Albers P, et al: Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05). Eur Urol. 55:1293–1299. 2009. View Article : Google Scholar : PubMed/NCBI
27	Bolenz C, Shariat SF, Fernández MI, et al: Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int. 103:302–306. 2009. View Article : Google Scholar : PubMed/NCBI
28	Abe T, Shinohara N, Muranaka M, et al: Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes. Eur J Surg Oncol. 36:1085–1091. 2010. View Article : Google Scholar : PubMed/NCBI
29	Lughezzani G, Jeldres C, Isbarn H, et al: A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology. 75:118–124. 2010. View Article : Google Scholar : PubMed/NCBI
30	Roscigno M, Shariat SF, Margulis V, et al: Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol. 181:2482–2489. 2009. View Article : Google Scholar : PubMed/NCBI